FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3024776685> ?p ?o ?g. }

• W3024776685 endingPage "104444" @default.
• W3024776685 startingPage "104444" @default.
• W3024776685 abstract "Approximately 5% of patients with coronavirus disease 2019 (COVID-19) develop a life-threatening pneumonia that often occurs in the setting of increased inflammation or “cytokine storm”. Anti-cytokine treatments are being evaluated but optimal patient selection remains unclear, and the aim of our study is to address this point. Between February 29 to April 6, 2020, 111 consecutive hospitalized patients with COVID-19 pneumonia were evaluated in a single centre retrospective study. Patients were divided in two groups: 42 severe cases (TOCI) with adverse prognostic features including raised CRP and IL-6 levels, who underwent anti-cytokine treatments, mostly tocilizumab, and 69 standard of care patients (SOC). In the TOCI group, all received anti-viral therapy and 40% also received glucocorticoids. In TOCI, 62% of cases were ventilated and there were three deaths (17.8 ± 10.6 days, mean follow up) with 7/26 cases remaining on ventilators, without improvement, and 17/26 developed bacterial superinfection. One fatality occurred in the 15 TOCI cases treated on noninvasive ventilation and one serious bacterial superinfection. Of the 69 cases in SOC, there was no fatalities and no bacterial complications. The TOCI group had higher baseline CRP and IL-6 elevations (p < 0.0001 for both) and higher neutrophils and lower lymphocyte levels (p = 0.04 and p = 0.001, respectively) with the TOCI ventilated patients having higher markers than non-ventilated TOCI patients. Higher inflammatory markers, more infections and worse outcomes characterized ventilated TOCI cases compared to ward based TOCI. Despite the confounding factors, this suggests that therapy time in anti-cytokine randomized trials will be key." @default.
• W3024776685 created "2020-05-21" @default.
• W3024776685 creator A5002584089 @default.
• W3024776685 creator A5006405170 @default.
• W3024776685 creator A5009666075 @default.
• W3024776685 creator A5013492063 @default.
• W3024776685 creator A5026803339 @default.
• W3024776685 creator A5044733599 @default.
• W3024776685 creator A5046294471 @default.
• W3024776685 creator A5048428887 @default.
• W3024776685 creator A5048523510 @default.
• W3024776685 creator A5071307383 @default.
• W3024776685 creator A5071692690 @default.
• W3024776685 creator A5091426526 @default.
• W3024776685 date "2020-08-01" @default.
• W3024776685 modified "2023-10-02" @default.
• W3024776685 title "Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care" @default.
• W3024776685 cites W1982906652 @default.
• W3024776685 cites W2418601731 @default.
• W3024776685 cites W2741385047 @default.
• W3024776685 cites W3001118548 @default.
• W3024776685 cites W3008090866 @default.
• W3024776685 cites W3008827533 @default.
• W3024776685 cites W3011610993 @default.
• W3024776685 cites W3013789297 @default.
• W3024776685 cites W3013843138 @default.
• W3024776685 cites W3014003872 @default.
• W3024776685 cites W3014333693 @default.
• W3024776685 cites W3014663601 @default.
• W3024776685 cites W3014803927 @default.
• W3024776685 cites W3015305373 @default.
• W3024776685 cites W3015522797 @default.
• W3024776685 cites W3015607499 @default.
• W3024776685 cites W3015696390 @default.
• W3024776685 cites W3016222783 @default.
• W3024776685 cites W3016759737 @default.
• W3024776685 cites W3016913884 @default.
• W3024776685 cites W3165656738 @default.
• W3024776685 doi "https://doi.org/10.1016/j.jcv.2020.104444" @default.
• W3024776685 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7227535" @default.
• W3024776685 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32570043" @default.
• W3024776685 hasPublicationYear "2020" @default.
• W3024776685 type Work @default.
• W3024776685 sameAs 3024776685 @default.
• W3024776685 citedByCount "129" @default.
• W3024776685 countsByYear W30247766852020 @default.
• W3024776685 countsByYear W30247766852021 @default.
• W3024776685 countsByYear W30247766852022 @default.
• W3024776685 countsByYear W30247766852023 @default.
• W3024776685 crossrefType "journal-article" @default.
• W3024776685 hasAuthorship W3024776685A5002584089 @default.
• W3024776685 hasAuthorship W3024776685A5006405170 @default.
• W3024776685 hasAuthorship W3024776685A5009666075 @default.
• W3024776685 hasAuthorship W3024776685A5013492063 @default.
• W3024776685 hasAuthorship W3024776685A5026803339 @default.
• W3024776685 hasAuthorship W3024776685A5044733599 @default.
• W3024776685 hasAuthorship W3024776685A5046294471 @default.
• W3024776685 hasAuthorship W3024776685A5048428887 @default.
• W3024776685 hasAuthorship W3024776685A5048523510 @default.
• W3024776685 hasAuthorship W3024776685A5071307383 @default.
• W3024776685 hasAuthorship W3024776685A5071692690 @default.
• W3024776685 hasAuthorship W3024776685A5091426526 @default.
• W3024776685 hasBestOaLocation W30247766851 @default.
• W3024776685 hasConcept C107130276 @default.
• W3024776685 hasConcept C11988809 @default.
• W3024776685 hasConcept C126322002 @default.
• W3024776685 hasConcept C167135981 @default.
• W3024776685 hasConcept C187316915 @default.
• W3024776685 hasConcept C203014093 @default.
• W3024776685 hasConcept C2522874641 @default.
• W3024776685 hasConcept C2777080012 @default.
• W3024776685 hasConcept C2777178219 @default.
• W3024776685 hasConcept C2777914695 @default.
• W3024776685 hasConcept C2778158872 @default.
• W3024776685 hasConcept C2778384902 @default.
• W3024776685 hasConcept C2778690821 @default.
• W3024776685 hasConcept C2779134260 @default.
• W3024776685 hasConcept C2779559532 @default.
• W3024776685 hasConcept C2779617845 @default.
• W3024776685 hasConcept C3008058167 @default.
• W3024776685 hasConcept C524204448 @default.
• W3024776685 hasConcept C71924100 @default.
• W3024776685 hasConcept C90924648 @default.
• W3024776685 hasConceptScore W3024776685C107130276 @default.
• W3024776685 hasConceptScore W3024776685C11988809 @default.
• W3024776685 hasConceptScore W3024776685C126322002 @default.
• W3024776685 hasConceptScore W3024776685C167135981 @default.
• W3024776685 hasConceptScore W3024776685C187316915 @default.
• W3024776685 hasConceptScore W3024776685C203014093 @default.
• W3024776685 hasConceptScore W3024776685C2522874641 @default.
• W3024776685 hasConceptScore W3024776685C2777080012 @default.
• W3024776685 hasConceptScore W3024776685C2777178219 @default.
• W3024776685 hasConceptScore W3024776685C2777914695 @default.
• W3024776685 hasConceptScore W3024776685C2778158872 @default.
• W3024776685 hasConceptScore W3024776685C2778384902 @default.
• W3024776685 hasConceptScore W3024776685C2778690821 @default.
• W3024776685 hasConceptScore W3024776685C2779134260 @default.
• W3024776685 hasConceptScore W3024776685C2779559532 @default.

• next